Apple and OpenEvidence launch experimental health chat app

Mario covers technology in health care, including FDA regulation of artificial intelligence; how Medicare pays for health tech; the use of AI in clinical care; mental health chatbots; and consumer wearables. He’s also the co-author of the free, twice weekly STAT Health Tech newsletter. You can reach Mario on Signal at mariojoze.13.

Brittany Trang, Ph.D., covers AI in health and medicine: Does it actually work? Who benefits, or might be harmed? She writes the weekly AI Prognosis newsletter. Follow her on Threads, Mastodon, and Bluesky. You can reach Brittany on Signal at btrang.01.

LAS VEGAS — Apple and OpenEvidence on Sunday launched a study based around an experimental artificial intelligence-powered health chat application, hinting at possible new directions for both companies.

Sumbul Desai, Apple’s vice president of health and fitness, explained that the company’s commitment to scientific rigor motivated the study, which aims to better understand how consumers interact with conversational health AI chatbots. “We’re studying what builds user trust, how people comprehend responses, the quality of responses, and we wanted to work with a clinically grounded partner, and that is OpenEvidence,” she said during the partnership announcement on stage at the HLTH conference in Las Vegas.

“OpenEvidence is the most trusted and loved brand product among doctors. Apple is the most trusted and loved brand and product among consumers, and especially health consumers,” said OpenEvidence CEO Daniel Nadler at the event. “So you have to bring these two things together. It’s like peanut butter and jelly.”

STAT+ Exclusive Story

STAT+





This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

View All Plans

To read the rest of this story subscribe to STAT+.

Subscribe

Connect

css.php